• First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
  • ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
  • Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
  • Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
  • Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
  • IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
  • Study Finds Entrectinib Safe, Effective for Patients with Melanoma and Other Cancers
  • Combining IMO-2125 and Yervoy Shows Promise in Certain Metastatic Melanoma Patients
  • Bacteria-derived Therapy AdVCA0848 Improves Survival in Mice with Melanoma, Study Indicates
  • Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial
  • Early-stage Eye Melanoma Trial Tests Less-invasive Treatment Approach
  • Nanoparticles Carrying Anticancer Medication May Be New Weapon Against Melanoma